News

Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?
LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.
MedPage Today on MSN19h
GLP-1 Drugs Linked to GERD; Best Upfront Approach for H. Pylori? AI in Colonoscopy
A similar study in Gastro Hep Advances found higher odds of GERD and gastroparesis among patients with type 2 diabetes taking GLP-1 agonists versus SGLT-2 inhibitors, but lower odds of acute ...